Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |